The full data from AstraZeneca's phase 3 BaxHTN trial of baxdrostat has raised hope of an important new treatment option for people who struggle to control their blood pressure with current therapies.
Specifically, the MHRA approved Zynyz as a first- and second-line treatment for adults with advanced squamous cell carcinoma ...
The approval gives Lilly first-mover advantage in China – the world's second-largest pharma market – and an edge over Novo, ...
Earlier this year I was sent a certificate showing 99.6% purity. It had a lab name, a test date, and a clean chromatogram. It ...
Hims & Hers is also offering compounded formulations of other unapproved peptides, including sermorelin, which some people ...
Reports are emerging that the Commissioner's National Priority Voucher (CNPV) scheme launched by former FDA Commissioner ...
Private equity firm Blackstone Life Sciences has agreed to provide up to $1.5 billion in funding to Pfizer for the ...
Ahead of World Diabetes Day on Saturday, Novo has said it will provide $200 million over the next 10 years to support World ...
The FDA has ordered all GLP-1 receptor agonist manufacturers to add a warning to the label of their products for a rare eye ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results